Genotype-Driven Neoadjuvant Therapy for Locally Advanced Thyroid Cancer: A Real-World Cohort Study
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Clinical Trials Related to Lenvatinib
Related studies linked through entity extraction aliases.
A Study of BL-B01D1 Monotherapy, BL-B01D1 in Combination With Lenvatinib, BL-B01D1 in Combination With PD-1 Monoclonal Antibody, and BL-B01D1 in Combination With PD-1 Monoclonal Antibody and Bevacizumab in Patients With Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Phase II Study of AK104 Combination With Lenvatinib Versus Lenvatinib for Second-line HCC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of BL-B01D1+TKI±Pembrolizumab in Patients With Locally Advanced or Metastatic Renal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Oncolytic Virus H101 Combined With Lenvatinib Plus Toripalimab Compared With FOLFOX in Patients With Advanced Biliary Tract Cancer (OPTIONS-06)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Lenvatinib Plus SIRT vs Lenvatinib in TACE-Refractory HCC
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Sintilimab Combined With Lenvatinib and HAIC for Neoadjuvant Therapy of Borderline Resectable HCC
- Status
- RECRUITING
- Phase
- PHASE2
STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Cryoablation Combined With Lenvatinib Plus Tislelizumab Compared With FOLFOX in Patients With Advanced Intrahepatic Cholangiocarcinoma (CASTLE-ZS-01)
- Status
- RECRUITING
- Phase
- PHASE2
Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial)
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
- Status
- RECRUITING
- Phase
- PHASE1
HIM Typing Guides the Treatment of Advanced First-Line Triple-Negative Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Efficacy and Safety of QL1706 Plus Lenvatinib As 2nd Line Theapy in Patients with Metastatic Esophageal Carcinoma After Disease Progression on ICIs Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
TACE Combined With Lenvatinib and PD-1 Inhibitor for Ruptured Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- NA
A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment
- Status
- RECRUITING
- Phase
- PHASE2
Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT
- Status
- RECRUITING
- Phase
- NA
Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Palliative Hepatectomy Combined With Targeted Therapy and Immunotherapy for Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1